To evaluate whether the PD1 peptide antagonists alter antigen-specific CD8 T-cell responses during immunization, we used a well-established vaccine model of malaria (the recombinant replication-defective adenovirus expressing the entire P. yoelii circumsporozoite protein; AdPyCS), which is known to be protective (32). The gene discussed is CD8A; the disease is malaria.